The aim of radiotherapy is to generate dose distributions that conform the treatment volume to the planning target volume while keeping the dose to the organs…
Monoclonal antibodies specifically bind to target cells or proteins and are therefore used as cancer diagnostics as well as therapeutics. The production of…
The invention describes a tracking device, software and method useful as navigation aid during medical interventions in soft tissue and organs such as liver.Further Information: …
Ovarian and highly aggressive endometrial carcinomas are the most common causes of cancer related deaths among gynaecological cancer diseases. Ovarian cancer…
The present invention relates to a method for the
photolithographic synthesis of biochips in which
photolabile protective groups of the…
Equine sarcoids are fibrosarcoma-like skin tumours with a prevalence of approximately 1–2 %. Strong evidence exists for a causative role of bo-vine…
The invention provides novel lithium salts of pentafluorophenylamide, in particular,
lithium pentafluorophenyl(trifluoromethylsulfonyl)imide (Li-PFTFSI)….
The inventive capacitive sensor enables precise determination of the oxidation stability of biodiesel during thermo-oxidative degradation. The so called…
The described invention uses for the first time a polysaccharide, hydroxyethyl starch (HES), for the controlled shielding/deshielding of polyplexes.Further…
The receptor for advanced glycation-end prod-ucts (RAGE) has been shown to play a central role not only in acute or chronic inflammatory diseases but also in…
Endostatin is an antiangiogenic protein first discovered in Folkman's laboratory at Childrens Hospital, Harvard Medical School, and Boston. The antitumor…
Fluorescence recovery after photobleaching
(FRAP) is a widely used technique to measure the
mobility and interactions of fluorescently labeled
…
Exosomes are nano-sized, secreted cell organelles that are released by a huge variety of different cell species, including mesenchymal stem cells (MSCs)….
Histone deacetylase inhibitors (HDACi) are prom-ising anticancer agents and are currently being evaluated in clinical trials. However, due to their unselective…
The identification of two H3.3 mutations allow the categorization of pediatric brain cancer patients into patients with grade IV pediatric GBM (P<0.0001) and…
Breast cancer has been recognized as a heterogeneous
disease that consists of different intrinsic
subtypes, including hormone receptor positive
…
Feedback
